tag:blogger.com,1999:blog-9217353884669167836.post3516034782344900373..comments2023-10-16T06:57:51.220-04:00Comments on Disgusted with the system: State suit targets AstraZeneca over antipsychotic medicineZoeyhttp://www.blogger.com/profile/00137007897874209945noreply@blogger.comBlogger1125tag:blogger.com,1999:blog-9217353884669167836.post-81499201143654748622008-08-13T07:35:00.000-04:002008-08-13T07:35:00.000-04:00Seroquel’s global sales last year were about $4 bi...Seroquel’s global sales last year were about $4 billion — second for the company only to Nexium, a heartburn drug that had sales of more than $5 billion last year.<BR/>And AstraZeneca’s outlook for Nexium got a lot brighter just a few months ago, when it cut a deal with Ranbaxy giving the generics shop the exclusive right to sell a copy of the drug — in 2014, six months before the AstraZeneca patent expires. Other companies are still fighting to bring generic Nexium to market, but Ranbaxy was seen as a key threat that could have brought a generic to market as soon as this year.<BR/>AstraZeneca’s stock was up more than 5% today in London, and it was up about 3% in U.S. trading this morning.<BR/>------------<BR/>blaire<BR/><BR/><A HREF="http://www.drugtreatments.com/alaska" REL="nofollow">Alaska Drug Treatment</A>johnsmithhttps://www.blogger.com/profile/00537036706099169057noreply@blogger.com